Incyte and Merck Expand Clinical Collaboration to Include Phase 3 Study Investigating the Combination of Epacadostat with Keytruda® (pembrolizumab) as First-line Treatment for Advanced...
Pivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma .Incyte Corporation (Nasdaq: INCY)...
MacroGenics and Merck to Collaborate on Immuno-Oncology Study Evaluating Margetuximab in Combination with KEYTRUDA® (pembrolizumab) for Advanced Gastric Cancer
Clinical trial to evaluate MacroGenics' Fc-optimized anti-HER2 antibody with Merck's anti-PD-1 therapy in patients with advanced HER2-positive gastric cancer MacroGenics, Inc. (Nasdaq: MGNX), a...
Boehringer Ingelheim named one of the most innovative companies worldwide
Ingelheim, 16 November 2015 - Boehringer Ingelheim has been named one of the most innovative companies worldwide in 2015. For the first time,...
Post-Merger with Ranbaxy, Sun Pharma Becomes 5th Largest Generic Company
Following the successful closure of the merger with drug maker Ranbaxy, Dilip Shanghvi-led Sun Pharma said on Wednesday that it is initiating the integration...
Sun Seals Ranbaxy Deal, To Invest $300 MN in R&D
Sun Pharmaceutical Industries, India’s largest drugmaker, on Wednesday announced the closure of its merger with Ranbaxy Laboratories and said the integration would deliver synergies...
We would like to make one plus one more than two: Uday Baldota
Sun Pharmaceutical Industries is in the process of closing its merger with Ranbaxy. The former's chief financial officer (CFO), Uday Baldota, talks to Digbijay...
Sun Pharmaceutical wins US approval to buy Ranbaxy
Sun Pharmaceutical Industries LtdBSE -0.35 % has won US approval to buy Ranbaxy Laboratories LtdBSE -0.61 % on condition that it sell its interest...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...